Clinical Trial Update: MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study evaluating MRI-guided neoadjuvant treatment de-escalation in stage II-III triple-negative breast cancer, which …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: TNBC, Triple Negative Breast Cancer, Early Breast Cancer | Phase 2 | Status: RECRUITING